Harold J Burstein. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » Advisory CommitteesAngiogenesis Inhibitors/economicsAngiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal/economicsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedBevacizumabBreast Neoplasms/drug therapyDrug ApprovalFemaleHumansUnited StatesUnited States Food and Drug Administration
Substances： See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedBevacizumab
Year: 2010 PMID： 20870630 DOI： 10.6004/jnccn.2010.0061
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908